Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Helen Jankowski"'
Publikováno v:
Nano Express, Vol 4, Iss 3, p 035003 (2023)
Extracellular vesicles are nano- to micro-sized structures that carry biomolecules between cells to coordinate cellular activity and communication. Isolation and characterisation must be standardised to better understand the role of extracellular ves
Externí odkaz:
https://doaj.org/article/baaa67fde1644e1295e42758c5724e30
Autor:
Joshua S. Brzozowski, Helen Jankowski, Danielle R. Bond, Siobhan B. McCague, Benjamin R. Munro, Melanie J. Predebon, Christopher J. Scarlett, Kathryn A. Skelding, Judith Weidenhofer
Publikováno v:
Lipids in Health and Disease, Vol 17, Iss 1, Pp 1-12 (2018)
Abstract Background Extracellular vesicles (EVs) are produced and secreted from most cells of the body and can be recovered in biological fluids. Although there has been extensive characterisation of the protein and nucleic acid component of EVs, the
Externí odkaz:
https://doaj.org/article/6424a2319668452684593037e2aca0af
Autor:
Melanie J. Predebon, Danielle R. Bond, Joshua Brzozowski, Helen Jankowski, Fiona Deane, Mark Tarleton, Aron A. Shaw, Adam McCluskey, Michael C. Bowyer, Judith Weidenhofer, Christopher J. Scarlett
Publikováno v:
Molecules, Vol 24, Iss 3, p 524 (2019)
Pancreatic cancer (PC) is a complex, heterogeneous disease with a dismal prognosis. Current therapies have failed to improve survival outcomes, urging the need for discovery of novel targeted treatments. Bispidinone derivatives have yet to be investi
Externí odkaz:
https://doaj.org/article/56d49fd19e824b2ab53b775f8ba3d930
Autor:
Christopher J. Scarlett, Séverine Roselli, Joshua S. Brzozowski, Richard G. S. Kahl, Helen Jankowski, Leonie K. Ashman, Judith Weidenhofer, Danielle R. Bond, William J. Muller, Mamta Pariyar, Claude Boucheix, Murray J. Cairns, Kelly A. Avery-Kiejda, Crystal Naudin
Publikováno v:
Cancers
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 795 (2020)
Volume 12
Issue 4
Cancers, Vol 12, Iss 4, p 795 (2020)
Breast cancer is the most commonly diagnosed and the second leading cause of cancer-related mortality among women worldwide. miR-518f-5p has been shown to modulate the expression of the metastasis suppressor CD9 in prostate cancer. However, the role
Autor:
Martin R. Larsen, Joshua S. Brzozowski, Kathryn A. Skelding, Matthew D. Dun, Rachel Burchell, Danielle R. Bond, Helen Jankowski, Christopher J. Scarlett, Nathan D. Smith, Crystal Naudin, Belinda J. Goldie, Judith Weidenhofer
Publikováno v:
Scientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
Brzozowski, J S, Bond, D R, Jankowski, H, Goldie, B J, Burchell, R, Naudin, C, Smith, N D, Scarlett, C J, Larsen, M R, Dun, M D, Skelding, K A & Weidenhofer, J 2018, ' Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion ', Scientific Reports, vol. 8, 8822 . https://doi.org/10.1038/s41598-018-27180-z
Brzozowski, J S, Bond, D R, Jankowski, H, Goldie, B J, Burchell, R, Naudin, C, Smith, N D, Scarlett, C J, Larsen, M R, Dun, M D, Skelding, K A & Weidenhofer, J 2018, ' Extracellular vesicles with altered tetraspanin CD9 and CD151 levels confer increased prostate cell motility and invasion ', Scientific Reports, vol. 8, 8822 . https://doi.org/10.1038/s41598-018-27180-z
To facilitate intercellular communication, cells release nano-sized, extracellular vesicles (EVs) to transfer biological cargo to both local and distant sites. EVs are enriched in tetraspanins, two of which (CD9 and CD151) have altered expression pat
Autor:
Christopher J. Scarlett, Danielle R. Bond, Belinda J. Goldie, Crystal Naudin, Murray J. Cairns, Adam P. Carroll, Helen Jankowski, Joshua S. Brzozowski, Leonie K. Ashman, Judith Weidenhofer
Publikováno v:
Oncotarget
// Danielle R. Bond 1, 4 , Crystal Naudin 1, 3 , Adam P. Carroll 1, 5 , Belinda J. Goldie 1, 2 , Joshua S. Brzozowski 1 , Helen M. Jankowski 1 , Murray J. Cairns 1, 5 , Leonie K. Ashman 1 , Christopher J. Scarlett 4 and Judith Weidenhofer 1 1 School
Autor:
Danielle R. Bond, Joshua S. Brzozowski, Judith Weidenhofer, Mark Tarleton, Christopher J. Scarlett, Melanie J. Predebon, Aron A Shaw, Michael C. Bowyer, Fiona M. Deane, Adam McCluskey, Helen Jankowski
Publikováno v:
Molecules, Vol 24, Iss 3, p 524 (2019)
Molecules
Volume 24
Issue 3
Molecules
Volume 24
Issue 3
Pancreatic cancer (PC) is a complex, heterogeneous disease with a dismal prognosis. Current therapies have failed to improve survival outcomes, urging the need for discovery of novel targeted treatments. Bispidinone derivatives have yet to be investi
Autor:
Helen Jankowski, Alexander Hoffman, Kathryn A. Skelding, Elizabeth A Pearsall, Mengna Chi, Jackson Mayhew, Joshua S. Brzozowski, Hamish M. Evans, Jackson Gilchrist
Publikováno v:
Scientific Reports
Calcium/calmodulin-stimulated protein kinase II (CaMKII) is a multi-functional kinase that controls a range of cellular functions, including proliferation, differentiation and apoptosis. The biological properties of CaMKII are regulated by multi-site
Autor:
Christopher J. Scarlett, Costas E. Stathopoulos, Judith Weidenhofer, Chloe D. Goldsmith, Helen Jankowski, Paul D. Roach, Danielle R. Bond
Publikováno v:
International Journal of Molecular Sciences, Vol 19, Iss 7, p 1937 (2018)
International Journal of Molecular Sciences
Volume 19
Issue 7
International Journal of Molecular Sciences
Volume 19
Issue 7
Current chemotherapy drugs for pancreatic cancer only offer an increase in survival of up to six months. Additionally, they are highly toxic to normal tissues, drastically affecting the quality of life of patients. Therefore, the search for novel age
Autor:
Danielle R. Bond, Judith Weidenhofer, Costas E. Stathopoulos, Christopher J. Scarlett, Chloe D. Goldsmith, Paul D. Roach, Helen Jankowski
Publikováno v:
Cancer Research. 77:2177-2177
Pancreatic cancer is a devastating disease with a 5-year survival rate of less than 5%. Resistance to conventional treatment options and toxicity of current chemotherapy agents (gemcitabine) makes pancreatic cancer a target for the development of nov